Compliance Program. Except as disclosed in the Registration Statement and the Prospectus, the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the TGA and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or TGA); except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 3 contracts
Samples: Alterity Therapeutics LTD, Prana Biotechnology LTD, Prana Biotechnology LTD
Compliance Program. Except as disclosed in the Registration Statement and or the Prospectus, the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the TGA FDA and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or TGAFDA); , except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 3 contracts
Samples: Icagen Inc, Marshall Edwards Inc, Icagen Inc
Compliance Program. Except as disclosed in the Registration Statement and or the Prospectus, the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the TGA FDA and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or TGAFDA); , except where the failure to establish and administer such noncompliance compliance program would not reasonably be expected to have a Material Adverse Effect.
Appears in 2 contracts
Samples: Biocryst Pharmaceuticals Inc, Curis Inc
Compliance Program. Except as disclosed in the Registration Statement and the ProspectusProspectuses, the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the TGA FDA and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or TGA); FDA) except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 2 contracts
Samples: Sales Agreement (Aeterna Zentaris Inc.), Sales Agreement (Aeterna Zentaris Inc.)
Compliance Program. Except To the extent legally required to conduct its business as disclosed described in the Registration Statement and the Prospectus, the Company has established and administers a compliance program program, applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the TGA FDA and any other foreign, federal, state or local governmental or regulatory authority performing functions function similar to those performed by the FDA or TGAFDA); except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 2 contracts
Samples: Market Issuance Sales Agreement (Geron Corp), Geron Corp
Compliance Program. Except as disclosed in the Registration Statement Statements and the Prospectus, the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the TGA FDA and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or TGAFDA); except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 1 contract
Compliance Program. Except as disclosed in the Registration Statement and or the ProspectusProspectus (including the Incorporated Documents), the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the TGA FDA and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or TGAFDA); except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 1 contract
Samples: Cerus Corp
Compliance Program. Except as disclosed in the Registration Statement and the Prospectus, the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the TGA EMA, and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or TGAEMA); except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 1 contract
Samples: Pluristem Therapeutics Inc
Compliance Program. Except as disclosed in the Registration Statement and the Prospectus, the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the TGA FDA and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or TGAFDA); , except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 1 contract
Samples: Aastrom Biosciences Inc